Predictive Factors and Outcomes in Patients With Severe Postoperative Anemia
Following Total Joint Arthroplasty
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Results

Introduction
• Perioperative allogenic blood transfusions (ABT) have
demonstrated associations with poor outcomes and
increased complication rates following total joint
1
arthroplasty (TJA)
• Recent strides in blood conservation methods have
been made, including multimodal blood management,
tranexamic acid (TXA) use, and restrictive transfusion
strategies in order to reduce risk associated with
2
transfusion
• While the literature on transfusions and outcomes is
extensive, the consequences of low postoperative
hemoglobin is less well defined
• This study aimed to identify factors and consequences
associated with severe anemia (hemoglobin <8g/dL)
following primary TJA.

Materials and Methods
• A retrospective review was conducted of all the
elective primary TJA at a single tertiary care medical
center from January 2017 to December 2018
• One thousand six hundred and thirty-five cases were
stratified based on the development of severe
postoperative anemia, and compared based on patient
preoperative hemoglobin, comorbidities,
demographics, intraoperative variables, and
postoperative outcomes
• Logistic regression was used to identify independent
predictors of severe postoperative anemia.

Variable

OR (95% CI)

P-value

Preoperative hemoglobin level

3.0 (2.4–3.7)†

<0.001

Hip arthroplasty

2.1 (1.3–3.4) ‡

0.004

Surgical duration

2.0 (1.6–2.6)§

<0.001

Female sex

1.4 (0.77–2.5)

0.274

General anesthesia

1.1 (0.55–2.4)||

0.717

CCI value

1.1 (0.99–1.3)¶

0.072

Age

1.1 (0.92–1.2)#

0.443

0.90 (0.86–0.94)**
0.42 (0.20–0.85)

<0.001
0.016

Body mass index value
Tranexamic acid use

• Surgical duration (per 30 minute increase),
preoperative hemoglobin (per 1g/dL decrease),
and THA vs. TKA were independently associated
with severe postoperative anemia (Table 1)
• Use of TXA and body mass index (per 1kg/m2
increase) were protective against it (Table 1)
• Severe postoperative anemia was associated with
acute kidney injury (AKI), longer length of stay
(LOS), and 90-day emergency department
visits/readmissions (Table 2)

Table 1. Multivariable odds of severe postoperative anemia* after primary total joint arthroplasty in
1,583 cases from 2017–2018
CCI, Charlson Comorbidity Index; CI, confidence interval; OR, odds ratio.
*Defined as hemoglobin level < 8 g/dL. †Per 1-g/dL decrease. ‡Referent is knee arthroplasty. §Per 30-minute
increase. ||Referent is neuraxial anesthesia. ¶Per 1-point increase. #Per 5-year increase. **Per 1-unit increase.

Conclusions

N (%)
Outcome
Lowest postoperative
hemoglobin level (g/dL)
Any transfusion administered
Duration of hospital stay (h)
Acute kidney injury
ED visit/readmission within
90 d

All Cases (n =
1,583)

Severe
Postoperative
Anemia (n = 98)

No Severe
P-value
Postoperative
Anemia (n = 1,485)

10 ± 1.5

7.3 ± 0.6

11 ± 1.3

<0.001

27 (2)
41 ± 27†
33 (2)

24 (24)
82 ± 69†
8 (8)

3 (<1)
38 ± 18†
25 (2)

<0.001
<0.001
<0.001

79 (5)

12 (15)

67 (5)

0.001

After Excluding Transfused Patients

Duration of hospital stay
40 ± 20†
70 ± 39†
38 ± 18†
<0.001
(hours)
Acute kidney injury
30 (2)
5 (7)
25 (2)
0.002
ED visit/readmission within
76 (5)
9 (12)
67 (5)
0.003
90 d
Table 2. Postoperative outcomes of 1,583 primary total joint arthroplasty cases from 2017–2018, by
development of severe postoperative anemia*
ED, emergency department; pRBC, packed red blood cells. *Defined as hemoglobin level < 8 g/dL.
†Expressed as mean ± standard deviation.

• Longer duration of surgery, lower preoperative
hemoglobin, and THA are all associated with severe
postoperative anemia, and lead to complications of
AKI, increased LOS, and higher readmission rates
• As the incidence of fast-track TJA and outpatient
surgery steadily increase, reducing the extent of
postoperative anemia is essential for patient
outcomes.
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